Brain metastasis as the first and only metastatic relapse site portends worse survival in patients with advanced HER2 + breast cancer
Laura Noteware, Sarah Sammons(Dana-Farber Cancer Institute), James E. Herndon(Duke University), Carey K. Anders(Duke University), Laura Alder(Duke Medical Center), Nicole Dalal(University of California, San Francisco), William Giles(Duke Medical Center), Amanda E.D. Van Swearingen(Duke Cancer Institute), Gloria Broadwater, Scott Floyd(Duke University)
Cited by 6
Related Papers
Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer
|New England Journal of Medicine|2019|1.3k
Brain metastases
|Nature Reviews Disease Primers|2019|1.1k
Young Age at Diagnosis Correlates With Worse Prognosis and Defines a Subset of Breast Cancers With Shared Patterns of Gene Expression
|Journal of Clinical Oncology|2008|917
Breast Cancer Before Age 40 Years
|Seminars in Oncology|2009|795
Biology, Metastatic Patterns, and Treatment of Patients with Triple-Negative Breast Cancer
|Clinical Breast Cancer|2009|644